Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma
Open Access
- 1 August 2019
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 6203-6216
Abstract
Background: Hepatocellular carcinoma (HCC) is a prevalent malignant tumor. Long non-coding RNAs (lncRNAs) have been demonstrated to be abnormally expressed in many tumors and act as crucial regulators in various biological processes. However, the expression and function of the recently identified macrophage-associated lncRNA ELMO1 antisense RNA 1 (ELMO1-AS1) in HCC are unclear. Methods: The expression of ELMO1-AS1 was determined in HCC tissues and adjacent nontumorous tissues by quantitative real-time polymerase chain reaction (qRT-PCR). The Kaplan-Meier survival analysis and Cox regression analysis were performed to establish the correlation between the expression level and survival of HCC patients in a training set and a validation set, respectively. The overexpression experiments were also conducted to investigate the biological role of ELMO1-AS1 in HCC cells. Results: We uncovered that ELMO1-AS1 was significantly downregulated in HCC tissues, and high expression of ELMO1-AS1 is correlated with optimistic treatment outcome suggesting its potential as an independent prognostic biomarker for HCC. It was also found that overexpression of ELMO1-AS1 in HCC cells suppressed cell proliferation, migration and invasion and engulfment and cell motility 1 (ELMO1) may be a target of ELMO1-AS1. Conclusion: Our results suggested that macrophage-associated lncRNA ELMO1-AS1 could be a crucial regulator involved in HCC progression and considered as a potential prognostic biomarker and therapeutic target for HCC.Keywords
This publication has 38 references indexed in Scilit:
- Long Noncoding RNAs in Cancer: From Function to TranslationTrends in Cancer, 2015
- Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionScientific Reports, 2015
- RETRACTED ARTICLE: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinomaOncogene, 2015
- The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinomaCancer Letters, 2015
- The multilayered complexity of ceRNA crosstalk and competitionNature, 2014
- PBX3 promotes migration and invasion of colorectal cancer cellsviaactivation of MAPK/ERK signaling pathwayWorld Journal of Gastroenterology, 2014
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Accessories to the Crime: Functions of Cells Recruited to the Tumor MicroenvironmentCancer Cell, 2012
- Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targetsActa Pharmacologica Sinica, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010